BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8643200)

  • 41. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
    De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients.
    Heguilén RM; Sciurano C; Bellusci AD; Fried P; Mittelman G; Rosa Diez G; Bernasconi AR
    Nephrol Dial Transplant; 2005 Mar; 20(3):591-7. PubMed ID: 15687112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Subacute glomerulonephritis--a contradiction to intermittent haemodialysis?].
    Lindqvist B; Michaelsson G; Nyström K
    Nord Med; 1967 Jul; 78(28):901-2. PubMed ID: 6028541
    [No Abstract]   [Full Text] [Related]  

  • 44. Quality of dialysis water and dialysate in haemodialysis centres: Highlight for occurrence of non-fermenting gram-negative bacilli.
    Anversa L; Romani CD; Caria ES; Saeki EK; Nascentes GAN; Garbelotti M; Stancari RCA; Dantas STA; Rall VLM; Ruiz LS; Camargo CH; Richini-Pereira VB
    J Appl Microbiol; 2022 Apr; 132(4):3416-3429. PubMed ID: 35108426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Corynebacterium group JK endocarditis in a haemodialysis patient.
    Martinez-Vea A; Costa J; Garcia C; Bardají A; Ridao C; Ribas M; Richart C; Oliver JA
    Nephrol Dial Transplant; 1993; 8(2):177-9. PubMed ID: 8384342
    [No Abstract]   [Full Text] [Related]  

  • 46. Microbiologic contamination of liquid bicarbonate concentrate for hemodialysis.
    Ebben JP; Hirsch DN; Luehmann DA; Collins AJ; Keshaviah PR
    ASAIO Trans; 1987; 33(3):269-73. PubMed ID: 3675952
    [No Abstract]   [Full Text] [Related]  

  • 47. [Management of hemodialysis patient subject to medical-nuclear investigation].
    Granata A; Sessa C; Fiorini F; Randone S; Di Nicolò P; Zanoli L; Piranio S
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Zinc metabolism in patients with chronic uremia].
    Adamiec R; Uzar J
    Postepy Hig Med Dosw; 1986; 40(2):239-47. PubMed ID: 3532077
    [No Abstract]   [Full Text] [Related]  

  • 49. Impact of contaminated dialysate on long-term haemodialysis-related complications: is it really that important?
    Nubé MJ; Grooteman MP
    Nephrol Dial Transplant; 2001 Oct; 16(10):1986-91. PubMed ID: 11572884
    [No Abstract]   [Full Text] [Related]  

  • 50. [Physiopathology and clinical aspects of the sub-dialysis syndrome].
    Giovannetti S; Rindi P; Biagini M; Rizzo G
    Minerva Nefrol; 1972; 19(2):93-5. PubMed ID: 4377454
    [No Abstract]   [Full Text] [Related]  

  • 51. [Exchangeable sodium and water spaces in chronic uremia during intermittent hemodialytic treatment].
    Romagnoli GF; Mendola R; Bruschi E; Borsatti A; Muolo A; Mioni G; Huber W
    Minerva Nefrol; 1968; 15(5):336-41. PubMed ID: 5743462
    [No Abstract]   [Full Text] [Related]  

  • 52. Preventing/treating hypophosphatemia by adding phosphate to the dialysate.
    Sam R; Tang HL; Kjellstrand CM; Ing TS
    Int J Artif Organs; 2015 Dec; 38(12):671-2. PubMed ID: 26689145
    [No Abstract]   [Full Text] [Related]  

  • 53. Nystagmus during dialysis therapy for uremia.
    Rosen JA; Nicotera J
    Trans Am Neurol Assoc; 1967; 92():283. PubMed ID: 5634062
    [No Abstract]   [Full Text] [Related]  

  • 54. The Journal of Infection Control Nursing. Banishing the bacteria.
    Hartley J
    Nurs Times; 1988 Jun 1-7; 84(22):71-2. PubMed ID: 3393448
    [No Abstract]   [Full Text] [Related]  

  • 55. Microbial content in a non-sterile concentrated haemodialysis solution.
    Fregerslev S
    Dan Tidsskr Farm; 1970; 44(8):332-7. PubMed ID: 5485809
    [No Abstract]   [Full Text] [Related]  

  • 56. Acute manganese intoxication and pancreatitis in a patient treated with a contaminated dialysate.
    Taylor PA; Price JD
    Can Med Assoc J; 1982 Mar; 126(5):503-5. PubMed ID: 7066808
    [No Abstract]   [Full Text] [Related]  

  • 57. Which level of cytokine production is critical in haemodialysis?
    Cappelli G; DiFelice A; Perrone S; Ballestri M; Bonucchi D; Savazzi AM; Ciuffreda A; Lusvarghi E
    Nephrol Dial Transplant; 1998; 13 Suppl 7():55-60. PubMed ID: 9870439
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patients suffer pyrogenic reactions in Philadelphia dialysis units.
    Lefton CK
    Nephrol News Issues; 1994 Dec; 8(12):10. PubMed ID: 7800065
    [No Abstract]   [Full Text] [Related]  

  • 59. Rise in intraocular pressure during dialysis.
    Dujić M; Jovanović D; Marković P
    Clin Nephrol; 1995 Nov; 44(5):348. PubMed ID: 8605723
    [No Abstract]   [Full Text] [Related]  

  • 60. Lipid metabolism in patients on regular dialysis treatment.
    Ponticelli C
    Int J Artif Organs; 1978 Sep; 1(5):215-7. PubMed ID: 689763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.